Skip to Content

CD19 CAR T-Cell Therapy: A New Frontier in Autoimmune Disease Remission

Achieving long-term remission in autoimmune diseases such as systemic lupus erythematosus (SLE), idiopathic inflammatory myositis (IIM), and systemic sclerosis (SSc) is challenging and often requires prolonged treatment courses with varying success. In this talk, Dr. Mueller will discuss the challenges these severe autoimmune diseases present and how CD19 CAR T-cells offer a potential treatment where other therapies have failed. With a focus on the impressive data from their treatments, including complete remission in all patients and the intriguing biological aspects of the therapy, this video is set to provide in-depth insights into the future of autoimmune disease treatment.

Fabian Mueller

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top